CDC’s National Healthcare Safety Network is the nation’s most widely used healthcare-associated infection tracking system.

Original title: “5-Step Enrollment for Ambulatory Surgery Centers”

The Administrator of the WTC Health Program received a petition (Petition 026) to add "Anti GBM Disease Glomerulonephritis (Anti-Glomerular Basement Membrane Disease)" to the List of WTC- Related Health Conditions. Upon reviewing the scientific and medical literature, including information provided by the petitioner, the Administrator has determined that there is insufficient evidence available to support taking further action at this time regarding anti- GBM glomerulonephritis. The Administrato

Original title: “World Trade Center (WTC) Health Program; Petition 026-Anti-Glomerular Basement Membrane (Anti-GBM) Glomerulonephritis; Finding of Insufficient Evidence”

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled "General Considerations for the Use of New Approach Methodologies in Drug Development." The purpose of this draft guidance is to provide drug developers with a validation framework and general recommendations for using new approach methodologies (NAMs) in drug development. Although animal toxicity studies have proved to be a critical method to identify potential risks to

Original title: “General Considerations for the Use of New Approach Methodologies in Drug Development; Draft Guidance for Industry; Availability”

Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Original title: “HR 7967: To require the Secretary of Health and Human Services to revise the Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and to require the Secretary of Transportation to issue regulations to include testing for methadone use in Department of Transportation drug tests.”

Referred to the House Committee on the Judiciary.

Original title: “HR 7961: To exempt H-1B health care workers from the restriction under the Presidential Proclamation entitled "Restriction on Entry of Certain Nonimmigrant Workers", and for other purposes.”

Referred to the House Committee on Energy and Commerce.

Original title: “HR 7956: State Offices of Rural Health Program Reauthorization Act of 2026”

Referred to the House Committee on Energy and Commerce.

Original title: “HR 7953: To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.”

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)

Original title: “S 4110: A bill to revise and extend health workforce programs under title VII of the Public Health Service Act.”

Sponsor introductory remarks on measure. (CR H2535)

Original title: “HR 7877: To require the Secretary of Health and Human Services to establish a demonstration program to test mandatory coverage of treatment for wound care for epidermolysis bullosa under the Medicaid program.”

Heath Secretary Robert F. Kennedy Jr.’s efforts to overhaul vaccine policy are likely illegal, a Massachusetts District Court Judge ruled; Structure’s GLP-1 weight loss pill succeeds in Phase 2 while Rhythm’s Phase 3 basket trial fails to find the beat; Eli Lilly warns of potential safety risks of taking compounded tirzepatide, and Novo Nordisk is hit with an FDA warning letter regarding adverse events potentially linked to Ozempic.

Original title: “Kennedy’s Vaccine Agenda Stalled, Structure’s ‘Competitive’ Obesity Pill, Novo’s Warning Letter”

EMA launched three major new features of PRIME, the Agency’s scheme to enhance support for the development of medicines targeting an unmet medical need. After the completion of…, "Over the ten years since its launch, PRIME has continued to evolve to keep pace with scientific innovation and accelerate the development and assessment of…, The results of the pilot indicate that the new PRIME features promote enhanced regulatory agility and better support to developers. They also come at a

Original title: “New PRIME tools to accelerate development of medicines in the EU”

The U.S. Food and Drug Administration today issued draft guidance intended to help drug developers validate new approach methodologies (NAMs) to be used instead of animal testing in drug development, and to bring safe, effective drugs to market sooner based on human-centric data.

Original title: “FDA Releases Draft Guidance on Alternatives to Animal Testing in Drug Development ”

Read twice and referred to the Committee on Finance.

Original title: “S 3304: Medical Foods and Formulas Access Act of 2025”

Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

Original title: “S 3183: Healthy Lungs for Heroes Act of 2025”

Referred to the House Committee on Armed Services.

Original title: “HR 7745: To establish certain requirements relating to wellness checks for the health and welfare of certain members of the Armed Forces, and for other purposes.”

CDC has developed tools to help state and local health departments prevent tickborne disease.

Original title: “Communication Resources”

Original title: “Health Insurance Coverage”

Original title: “Cholesterol”

Senators Cotton and Kaine introduce the Rx ACCESS Act to improve pharmacy access for active-duty military families.Quiver AI SummarySenators Cotton and Kaine introduce bipartisan legislation: On March 17, 2026, Senator Tom Cotton (R-AR) and Senator Tim Kaine (D-VA) introduced the Rx ACCESS ... Senators Cotton and Kaine introduce the Rx ACCESS Act to improve pharmacy access for active-duty military families.Quiver AI SummarySenators Cotton and Kaine introduce bipartisan legislation: On March 17, 2026, Senator Tom Cotton (R-AR) and Senator Tim Kaine (D-VA) introduced the Rx ACCESS Act, which aims to enhance pharmacy access for active-duty military personnel and their families by addressing reimbursement practices within the TRICARE progr Key provisions outlined: The Rx ACCESS Act requires pharmacy benefit managers to reimburse pharmacies at the actual cost of drugs or the national average drug acquisition cost, and mandates annual audits of TRICARE pharmacy data to ensure adequate access to medications. Senators Cotton and Kaine introduce bipartisan legislation: On March 17, 2026, Senator Tom Cotton (R-AR) and Senator Tim Kaine (D-VA) introduced the Rx ACCESS Act, which aims to enhance pharmacy access for active-duty military personnel and their families by addressing reimbursement practices within the TRICARE program. S.3839: Ratepayer Affordability and Transparency in Energy Act of 2026

Original title: “Press Release: Cotton and Kaine Introduce Bipartisan Legislation to Improve Pharmacy Access for Military Families | Quiver Quantitative”

The Food and Drug Administration (FDA) is proposing to require the filing of a premarket approval application (PMA) for blood irradiators intended to irradiate intraoperatively salvaged blood for cancer patients undergoing surgery to assist in prevention of metastasis, which are unclassified, preamendments devices. FDA is summarizing its proposed findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the devices to meet PMA requirements of th

Original title: “Effective Date of Requirement for Premarket Approval Applications for Blood Irradiators Intended To Prevent Metastasis”